1. 多肽产品
  2. 多肽及其衍生物
  3. AAPDNRETF

AAPDNRETF 是 H-2Db 分子提呈的一个显性次要组织相容性抗原,该抗原在 C57BL/6 小鼠中表达,能被 C3H.SW 小鼠的 T 细胞识别,从而引发强烈的免疫应答。AAPDNRETF 可通过转移致敏 T 淋巴细胞,在经辐照的 C57BL/6 受体小鼠中引发移植物抗宿主病。AAPDNRETF 可用于移植物抗宿主病的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Custom Peptide Synthesis

AAPDNRETF

AAPDNRETF Chemical Structure

CAS No. : 179953-98-1

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

AAPDNRETF is a dominant minor histocompatibility antigen presented by H-2Db, which antigen is expressed in C57BL/6 mice and can be recognized by T cells from C3H.SW mice, thereby inducing a strong immune response. AAPDNRETF can induce graft-versus-host disease in irradiated C57BL/6 recipient mice via transfer of sensitized T lymphocytes. AAPDNRETF is applicable to the research of graft-versus-host disease[1].

体外研究
(In Vitro)

AAPDNRETF (0.01 nM-1 μM) 在极低浓度 (10 pM) 下即可有效致敏表达 H-2Db 的靶细胞 (如 T2Db 细胞),使其被小鼠效应 T 细胞 (CTL) 杀伤[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

AAPDNRETF (50-300 µg/只; s.c.; 间隔 7 天,共注射 2 次) 可在雄性 C3H.SW/SnJ 小鼠中诱导产生针对由 H-2Db 呈递的优势 C57BL/6 次要组织相容性抗原的强效、特异性细胞毒性 T 淋巴细胞应答[1]
AAPDNRETF (300 µg/只; s.c.; 间隔 7 天,共注射 2 次) 可诱导产生 T 淋巴细胞,此类细胞会在经辐照的雄性 C57BL/6J 受体小鼠中引发严重的非致死性移植物抗宿主病以及胸腺发育不全[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C3H.SW/SnJ (male, 8-20 wk old)[1]
Dosage: 50 µg; 100 µg; 300 µg
Administration: s.c.; administered twice at 7-day intervals
Result: Generated potent CTL responses that killed both unmanipulated C57BL/6 target cells and C3H.SW target cells coated with synthetic AAPDNRETF peptide.
Induced CTL activity comparable to that induced by priming with C57BL/6 cells.
Animal Model: C3H.SW/SnJ (male, 8-20 wk old, donor); C57BL/6J (male, 8-20 wk old, recipient, irradiated 950 rads)[1]
Dosage: 300 µg (donor priming)
Administration: s.c.; administered twice at 7-day intervals (donor priming)
Result: Caused 6/7 recipient mice to develop cutaneous GVHD (hair loss, erythematous lesions, skin ulcerations) starting around day 25, with lesions worsening up to day 60.
Induced significant thymic hypoplasia, with a 50% reduction in total Thy1.2+ thymocytes, CD4+CD8+ double positive thymocytes, CD4+TCRαβ high single positive thymocytes, and CD8+TCRαβ high single positive thymocytes compared to control recipients by day 60.
Maintained 100% recipient survival through day 60.
分子量

1020.05

Formula

C43H65N13O16

CAS 号
Sequence

Ala-Ala-Pro-Asp-Asn-Arg-Glu-Thr-Phe

Sequence Shortening

AAPDNRETF

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
AAPDNRETF
目录号:
HY-P11699
需求量: